← Companies|Durect (Innocoll)
DR

Durect (Innocoll)

DRRX·NASDAQCupertino CAFounded 199840 employees
Micro CapbiotechPublicHepatology
Platform: DUR-928 MASH
Market Cap
$0.05B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (DRRX)
Loading DRRX stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
MirirelsinDRR-3541Preclinical1ASOBCL-2IL-23iOCD
DRR-2203DRR-2203Phase 2/32RadioligandCDK2HER2HCCSLE
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2025-08-12
Mirirelsin Interim
OCD
Past
2028-01-16
DRR-2203 Ph3 Readout
Bladder Ca
Ph3 Readout
2030-02-14
DRR-2203 Ph3 Readout
HCC
Ph3 Readout